Zobrazeno 1 - 9
of 9
pro vyhledávání: '"J J, Pujol Tugores"'
Autor:
J. F. Noguera Aguilar, J. C. Vicens Arbona, R. Morales Soriano, J. Ibarra de la Rosa, A. Arrivi García-Ramos, M. Cuadra Coll, C. Dolz Abadía, J. J. Pujol Tugores
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 97, Iss 11, Pp 786-793 (2005)
Aim: to analyze qualitative short-time results of a new program for multidisciplinary liver evaluation in complex cases of liver metastasis from colorectal cancer. Patients and methods: 40 clinical consecutive evaluations with liver metastasis assess
Externí odkaz:
https://doaj.org/article/156e78355743484b9e5d0da5b831a51c
Autor:
J. F. Noguera Aguilar, I. Amengual Antich, A. Plaza Martínez, J. Ibarra de la Rosa, C. Tortajada Collado, A. Gamundí Gamundí, J. J. Pujol Tugores
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 97, Iss 9, Pp 637-647 (2005)
Background: an overexpression of cyclooxygenase-2 (COX-2) has been seen in colon tumors; therefore, COX-2 specific inhibitors may be used as preventive agents. The aim of this study was to investigate the effect of both selective and non-selective CO
Externí odkaz:
https://doaj.org/article/937f0630c9f046e48d8ddebd67b8375b
Autor:
J. F. Noguera Aguilar, I. Amengual Antich, J. M. Morón Canis, A. Plaza Martínez, J. A. Martínez Córcoles, C. Tortajada Collado, J. J. Pujol Tugores
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 97, Iss 6, Pp 405-415 (2005)
Aim: to investigate the effect of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib on the incidence of perianastomotic colonic tumors in a model of chemical carcinogenesis in the rat. Experimental design: experimental study with 45 male Spr
Externí odkaz:
https://doaj.org/article/9a267a5303514204b82f0f33655fe52d
Autor:
J. F. Noguera Aguilar, A. Plaza Martínez, I. Amengual Antich, J. M. Morón Camis, C. Tortajada Collado, J. J. Pujol Tugores
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 96, Iss 10, Pp 678-686 (2004)
Aim: to investigate the effect of a selective cyclooxigenase-2 (COX-2) inhibitor, rofecoxib, in the prevalence of experimental colon tumors in rats. Experimental design: experimental study with 35 male Sprague-Dawley rats, divided into four groups: a
Externí odkaz:
https://doaj.org/article/6cc5f4f691884343a683e635b94ede3e
Autor:
J. F. Noguera Aguilar, I. Amengual Antich, A. Plaza Martínez, C. Tortajada Collado, J. M. Morón Canis, J. J. Pujol Tugores
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 96, Iss 5, Pp 322-330 (2004)
Aim: to investigate the influence of different experimental manipulations in a model of colonic experimental carcinogenesis with pharmacological induction in the rat. Experimental design: a total of 90 Sprague-Dawley male rats, divided into three gro
Externí odkaz:
https://doaj.org/article/3636c73e48ef429698d2c6bd6805a881
Autor:
C. Tortajada Collado, JM Morón Canis, J. J. Pujol Tugores, J. A. Martínez Córcoles, A. Plaza Martínez, J. F. Noguera Aguilar, I. Amengual Antich
Publikováno v:
Revista Española de Enfermedades Digestivas v.97 n.6 2005
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Aim: to investigate the effect of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib on the incidence of perianastomotic colonic tumors in a model of chemical carcinogenesis in the rat. Experimental design: experimental study with 45 male Spr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9bdf7220094bd768c7a5811a74205e0
https://pubmed.ncbi.nlm.nih.gov/16011415
https://pubmed.ncbi.nlm.nih.gov/16011415
Autor:
A. Plaza Martínez, A. Gamundí Gamundí, J. F. Noguera Aguilar, C. Tortajada Collado, J Ibarra de la Rosa, I. Amengual Antich, J. J. Pujol Tugores
Publikováno v:
Revista Española de Enfermedades Digestivas v.97 n.9 2005
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Background: an overexpression of cyclooxygenase-2 (COX-2) has been seen in colon tumors; therefore, COX-2 specific inhibitors may be used as preventive agents. The aim of this study was to investigate the effect of both selective and non-selective CO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f44d2747d4f86d6cfc1c00257a5815d7
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082005000900004
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082005000900004
Autor:
C. Tortajada Collado, A. Plaza Martínez, J. F. Noguera Aguilar, J. M. Morón Canis, I. Amengual Antich, J. J. Pujol Tugores
Publikováno v:
Revista Española de Enfermedades Digestivas v.96 n.5 2004
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Aim: to investigate the influence of different experimental manipulations in a model of colonic experimental carcinogenesis with pharmacological induction in the rat. Experimental design: a total of 90 Sprague-Dawley male rats, divided into three gro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22dd53f1ed412e5ee62735f54037d50b
https://pubmed.ncbi.nlm.nih.gov/15180444
https://pubmed.ncbi.nlm.nih.gov/15180444
Autor:
J F, Noguera Aguilar, C, Tortajada Collado, J M, Morón Canis, A, Plaza Martínez, I, Amengual Antich, J J, Pujol Tugores
Publikováno v:
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 94(3)
To determine if an experimental model is valid for the study of perianastomotic recurrence in colorectal cancer, comparing it with previous experimental models.Experimental study with 40 male Sprague-Dawley rats, assigned to one of the study groups:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::07e8acad6d47a1506f7a70c1895c3558
https://pubmed.ncbi.nlm.nih.gov/12432594
https://pubmed.ncbi.nlm.nih.gov/12432594